Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing.
The bubble point test is the de facto standard for postproduction filter membrane integrity test in the radiopharmaceutical community. However, the bubble point test depends on a subjective visual assessment of bubbling rate that can be obscured by significant diffusive gas flows below the manufacturer's prescribed bubble point. To provide a more objective means to assess filter membrane integrity, this study evaluates the pressure-hold test as an alternative to the bubble point test. In our application of the pressure-hold test, the nonsterile side of the sterilizing filter is pressurized to 85% of the predetermined bubble point with nitrogen, the filter system is closed off from the pressurizing gas and the pressure is monitored over a prescribed time interval. The drop in pressure, which has a known relationship with diffusive gas flow, is used as a quantitative measure of membrane integrity. Characterization of the gas flow vs. pressure relationship of each filter/solution combination provides an objective and quantitative means for defining a critical value of pressure drop over which the membrane is indicated to be nonintegral. The method is applied to sterilizing filter integrity testing associated with the commonly produced radiopharmaceuticals, [(18)F]FDG and [(11)C]PIB. The method is shown to be robust, practical and amenable to automation in radiopharmaceutical manufacturing environments (e.g., hot cells).
Belanger
Anthony P
AP
Brigham and Women's Hospital, Boston, MA 02115, USA.
Byrne
John F
JF
Paolino
Justin M
JM
DeGrado
Timothy R
TR
D004867:Equipment Design; D019544:Equipment Failure Analysis; D005374:Filtration / Q000295:instrumentation* / Q000379:methods; D007553:Isotope Labeling / Q000295:instrumentation* / Q000379:methods; D008567:Membranes, Artificial; D011312:Pressure; D019275:Radiopharmaceuticals / Q000138:chemical synthesis*; D013242:Sterilization / Q000379:methods*
D008567:Membranes, Artificial; D019275:Radiopharmaceuticals